Bayer pharmaceuticals corproation | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Bayer pharmaceuticals corproation

Sort by

Viewing results 1‒25 of 677

News in-depthBayer AG
Bill Anderson: the Texan wrestling with Bayer’s mountain of pain
...In its pharmaceutical division, Bayer had to abandon a late-stage trial for its most promising drug last year, meaning it has only a few potential blockbusters left in its pipeline: treatments for prostate...
March 8, 2024
LexBayer AG
‘Broken’ Bayer needs bolder action Premium content
...Meanwhile, investors remain concerned Bayer may still have to increase its litigation provisions beyond the $6bn remaining. It needs further deals to replenish its pharmaceuticals pipeline....
March 7, 2024
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
LexPharmaceuticals sector
Bayer’s break-up looks inevitable Premium content
...The former Roche pharmaceuticals boss took on one of the most unenviable jobs in corporate Europe last June....
February 28, 2024
Bayer AG
Bayer CEO calls German group ‘badly broken’ as he holds off split
...“The public debate about Bayer’s future was too narrowly focused on a break-up,” he said, adding that Anderson was right to address Bayer’s underlying problems....
March 5, 2024
InterviewBayer AG
‘Zero chance’: Bayer chief rules out capital increase as investors slam turnaround plan
...The Texas native, who joined Bayer last summer after his predecessor Werner Baumann was pushed out, argued that Bayer first needed to focus on fixing its financial and operating problems, warning that the...
March 7, 2024
European companies
Activist investor Jeff Ubben to join Bayer’s supervisory board
...Alongside Ubben, Bayer nominated Nancy Simonian, the former CEO of US biotech company Syros Pharmaceuticals, and Lori Schechter, the former general counsel of US healthcare group McKesson, to join its supervisory...
February 29, 2024
FT Live
Global Pharma and Biotech Summit
Driving life sciences innovation in a disrupted world
Tuesday, 5 NovemberIn-Person & Online Conference
Bayer AG
Bayer slashes dividend by 95% as it steps up effort to cut debt
...Bayer paid a dividend of €2.40 for 2022. Analysts had expected Bayer to pay a dividend of €1.92 per share for 2023, a far more modest cut....
February 19, 2024
The crisis in European equities
Flight risk? London listings are the most vulnerable to New York’s allure
...Monsanto, which exposed Bayer to billions of dollars in litigation costs tied to the weedkiller glyphosate....
May 26, 2023
GSK PLC
GSK readies for pivotal ruling in Zantac cases
...Bayer has had to pay out billions of dollars after juries in litigation that was also led by Wisner found a link between a weedkiller developed by Monsanto, the US company the German group acquired in 2018...
April 24, 2024
Bayer AG
Bayer drug setback adds to new CEO’s problems
...But for the German group’s recently installed chief executive Bill Anderson, who has more than two decades of experience in the pharmaceuticals industry, such disappointments are just part of the game....
November 23, 2023
Bayer AG
Bayer shares plunge after blood-thinning drug trial halted
...that Roundup causes cancer, which Bayer denies....
November 20, 2023
Bayer AG
Bayer chief blasts conglomerate’s performance as ‘unacceptable’
...Bayer will give a detailed outlook for next year in March....
November 8, 2023
LexBayer AG
Bayer: cell therapy is a promising prescription Premium content
...These patent expiries, declining farm incomes and a battery of legal claims — estimated at €9bn by Berenberg’s Sebastian Bray — weigh on Bayer shares....
October 10, 2023
InterviewBayer AG
Bayer chief blames thin drug pipeline on ‘years of under-investment’
...Bayer last week abandoned a trial of blood-thinner asundexian after it did not work as hoped to treat heart disease....
November 26, 2023
LexAstraZeneca PLC
A decade after Pfizer, AstraZeneca needs to find its growth again
...AstraZeneca’s transformation is the sort of turnaround that others in the sector, such as Germany’s Bayer, need to replicate....
April 1, 2024
FT Live
Future of the Car
The technology and new business models shaping the next decade in automotive
Tuesday, 7 MaySancroft, Paternoster Square, London EC4M 7DQ, UK
News updates from March 5: China targets 5% GDP growth in 2024, Gold and Bitcoin hit record highs
What to watch in Europe today
...Corporate updates: German pharmaceutical company Bayer reports full-year results, alongside a strategy update from chief executive Bill Anderson, as the company faces numerous lawsuits in the US....
March 5, 2024
News updates from January 29: US mistook enemy drone as its own in Middle East attack, Evergrande ordered to liquidate
Risers and fallers in Europe
...Big share price moves in Europe today include Swiss cement giant Holcim, German pharmaceuticals group Bayer, and Dutch conglomerate Philips....
January 29, 2024
Transcript
Transcript: Cracks widen in Israel’s war cabinet
...[MUSIC PLAYING] German pharmaceutical company Bayer has been struggling with a ton of lawsuits related to its weedkiller called Roundup....
March 4, 2024
LexBayer AG
Monsanto: Anderson must uproot Bayer’s perennial problem Premium content
...Bayer has argued that cash flow from crop science and its consumer health unit help fund its growing pharmaceuticals pipeline....
July 25, 2023
News updates from July 25: Microsoft and Alphabet report rise in revenues, UK government faces £150bn bill to cover Bank of England’s QE losses
Bayer to take €2.5bn writedown on falling glyphosate prices
...German pharmaceuticals and agrochemicals group Bayer said it will take a €2.5bn writedown on glyphosate as prices — as well as demand — for the controversial weedkiller are falling....
July 24, 2023
Biotech
US biotech fundraising boom ends 2-year deal drought
...Metagenomi, a pre-clinical group backed by Moderna and Bayer, priced its $94mn IPO last week at the bottom of its target range, and fell 31 per cent on its first day of trading on Friday....
February 12, 2024
News updates from November 20: OpenAI staff threaten to quit unless directors resign, Argentine stocks rally over election of Milei
Risers and fallers in Europe
...Bayer: Shares in the German pharmaceutical company dropped as much as 18 per cent in early trading after it abandoned a late-stage trial of a blood thinning treatment due to a lack of efficacy....
November 20, 2023
Merck KGaA
Merck shares fall after multiple sclerosis drug trial fails
...Two weeks ago, shares in Merck’s rival Bayer dropped to their lowest level in a decade after the company abandoned a late-stage trial of a blood-thinning drug....
December 6, 2023
InterviewBayer AG
New Bayer chief plans a radically different style to cut bureaucracy
...Anderson joined Bayer in April and formally became CEO this month....
June 18, 2023
News updates from November 20: OpenAI staff threaten to quit unless directors resign, Argentine stocks rally over election of Milei
Risers and fallers in the US
...Pharmaceutical company Bristol Myers Squibb fell 3.5 per cent after the federal US drug regulator delayed its decision to expand the use of a cancer therapy and as rival Bayer stopped a late-stage study...
November 20, 2023

Previous pagePage 1 of 28Next page